Solstice Advanced Materials (SOLS) investor relations material

Executive summary

• Q3 net sales rose 8% YoY to $1.046B, led by Electronic Materials, Refrigerants and Healthcare Packaging.

• Adjusted EBITDA increased 13% to $265M; adjusted margin expanded 109 bps to 25.3%.

• Net income attributable to shareowners was $80M versus a $35M loss; full-year 2026 guidance was raised for a second consecutive quarter.

Financial highlights

• Organic sales growth was 8.3%, with volume contributing 6.0%, pricing 2.3% and FX reducing growth by 0.4%.

• Q3 diluted EPS was $0.50 and adjusted diluted EPS was $0.80; adjusted net income was $127M.

• Nine-month net sales rose 10% to $3.185B; attributable net income was $283M versus $196M.

• Nine-month operating cash flow was $693M; free cash flow was $368M after $325M of capital expenditures.

Outlook and guidance

• FY 2026 guidance: net sales $4.195B–$4.220B, adjusted EBITDA $1.05B–$1.06B and adjusted diluted EPS $2.90–$2.95; capex remains $420M–$440M.

• Q4 guidance: net sales $1.010B–$1.035B, adjusted EBITDA $246M–$256M and adjusted diluted EPS $0.57–$0.62; outlook assumes a stable macro environment.

• 2026 nuclear revenue is expected to rise 10%–15% YoY, including ~$30M of product-loan returns; Q4 revenue is expected to decline slightly due to shipment timing.

• Nuclear production is expected to exceed 10,000 tons in 2026; debottlenecking and Spokane expansion are expected to add capacity through 2027–2028.